Ireland Eyes ‘Conservative’ Savings Of €1bn Through Increased Uptake
Mooted Savings From Generics And Biosimilar Over Five Years
Off-patent industry association Medicines for Ireland believes the country could see ten-figure savings over the next five years if its penetration rates are brought in line with fellow EU member states, as well as the UK.
